About Sunrise International Labs
Sunrise International Labs is a Healthcare company based in Hyderabad (India) founded in 1986. It specializes in branded generics, formulations, and OTC drugs for pharmaceutical markets. It operates on a B2B model. The company has 68 employees. Its focus areas include Pharmaceuticals, Generic Drugs and Branded Generics and OTC.
Company details
Sunrise International Labs, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, generic drugs, and branded generics and otc. Specializes in branded generics, formulations, and OTC drugs for pharmaceutical markets. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Hyderabad, India
- Employees 68
- SectorsHealthcare
- Website sunriseinternationallabs.com
- Annual Revenue$4.29 M (USD)as on Mar 31, 2021
- Employee Count68
Associated legal entities of Sunrise International Labs
Sunrise International Labs is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Perdaman Pharmaceuticals Private Limited CIN U24233DL2008PTC174864 | Active | 04 Mar 2008 | New Delhi, Delhi | ₹28.8 Cr | 7 | View details | |
| Sunrise International Labs Limited CIN U24239TG1993PLC015367 | Active | 11 Feb 1993 | Hyderabad, Telangana | ₹21.4 Cr | 68 | 3 | View details |
Board of directors of Sunrise International Labs
The boards of the 2 registered companies of Sunrise International Labs currently have 5 directors; the longest-serving is Manoj Kumar Rambal, appointed in 2010. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manoj Kumar Rambal DIN 02527855 | Director | 15 May 2010 | 16 yrs 5 mo | Perdaman Pharmaceuticals Private Limited, Sunrise International Labs Limited |
| Usha Rambal DIN 02527942 | Director | 14 Oct 2010 | 16 yrs | Perdaman Pharmaceuticals Private Limited |
| Samir Madhukar Garud DIN 06681637 | Director | 20 Jun 2013 | 13 yrs 4 mo | Perdaman Pharmaceuticals Private Limited, Sunrise International Labs Limited |
| Vikas Rambal DIN 01759802 | Director | 01 Dec 2015 | 10 yrs 11 mo | Perdaman Pharmaceuticals Private Limited, Sunrise International Labs Limited |
| Sarojni Rambal DIN 02020944 | Director | 24 Jan 2017 | 9 yrs 9 mo | Perdaman Pharmaceuticals Private Limited |
Financials of Sunrise International Labs
Figures of Perdaman Pharmaceuticals Private Limited, the primary company behind Sunrise International Labs, for FY 2025. Revenue was ₹28.76 Cr (+4% year on year). Net profit was ₹21.9 Lakh (1% margin). EBITDA was ₹2.63 Cr (9% margin). Revenue has grown at a compounded annual rate of +1% over three years and +10% over five years.
- ₹28.76 CrRevenue · FY 2025 · +4% YoY
- ₹21.9 LakhNet profit · 1% margin
- ₹2.63 CrEBITDA · 9% margin
- ₹12.03 CrPaid-up capital
- +1%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Perdaman Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Sunrise International Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sunrise International Labs
Sunrise International Labs was founded in 1986.
Sunrise International Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sunrise International Labs has 68 employees.
Annual revenue of Sunrise International Labs is $4.29M as on Mar 31, 2021.
Sunrise International Labs, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, generic drugs, and branded generics and otc. Specializes in branded generics, formulations, and OTC drugs for pharmaceutical markets. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Sunrise International Labs is associated with 2 legal entities: Perdaman Pharmaceuticals Private Limited, Sunrise International Labs Limited.
The legal entities of Sunrise International Labs currently have 7 directors, including Vikas Rambal, Manoj Kumar Rambal, Usha Rambal and others.